Lite Strategy Inc (0JW9.L)

Healthcare | Medical Pharmaceuticals
Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$3.6M

Operating Margin

N/A

Free Cash Flow

-$20.8M

Debt / Assets

7.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Lite Strategy Inc (0JW9.L).
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 0 1,196,000 0 0
Cost of Revenue 0 598,000 169,000 61,000
Gross Profit 0 598,000 -169,000 -61,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,098,000 2,795,000 2,405,000 3,143,000
Operating Expenses 3,739,000 2,878,000 2,774,000 3,451,000
Operating Income -3,739,000 -2,878,000 -2,774,000 -3,451,000
Interest Expense 0 0 0 0
Income Before Tax -3,639,000 -2,688,000 -2,573,000 -2,677,000
Income Tax Expense 0 0 0 0
Net Income -3,639,000 -2,688,000 -2,573,000 -2,677,000
Per Share
EPS -0.12 -0.40 -0.39 -0.40
EPS Diluted 0.00 0.00 0.00 0.00